As of Apr 2, 2025, the Lemaitre Vascular stock's price-to-earnings ratio is 44.19. This results from the current EPS of $1.96 and stock price of $86.62. The PE ratio has decreased by 6% from the past four quarters average of 47.2.
The PE ratio of Lemaitre Vascular has averaged 39.21 over the last ten years. The current price-to-earnings ratio of 44.19 is 13% more than the historical average. In the past ten years, LMAT's PE ratio reached its highest point in the Jun 2023 quarter at 59.02, when the stock price was $67.28 and the EPS was $1.14. The lowest point was recorded in the Dec 2018 quarter, when it reached 20.03 with a price of $23.64 and an EPS of $1.18.
Maximum annual increase: 137.32% in 2011
Maximum annual decrease: -64.36% in 2010
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 47.01 | 12.63% | $92.14 | $1.96 |
2023 | 41.74 | -14.75% | $56.76 | $1.36 |
2022 | 48.96 | 23.79% | $46.02 | $0.94 |
2021 | 39.55 | 2.54% | $50.23 | $1.27 |
2020 | 38.57 | -2.38% | $40.5 | $1.05 |
2019 | 39.51 | 97.25% | $35.95 | $0.91 |
2018 | 20.03 | -42.76% | $23.64 | $1.18 |
2017 | 34.99 | -21.3% | $31.84 | $0.91 |
2016 | 44.46 | 13.42% | $25.34 | $0.57 |
2015 | 39.2 | 22.96% | $17.25 | $0.44 |
2014 | 31.88 | -16.41% | $7.65 | $0.24 |
2013 | 38.14 | 12.97% | $8.01 | $0.21 |
2012 | 33.76 | -20.17% | $5.74 | $0.17 |
2011 | 42.29 | 137.32% | $5.92 | $0.14 |
2010 | 17.82 | -64.36% | $6.77 | $0.38 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 47.01 | -5.87% | $92.14 | $1.96 |
Sep 2024 | 49.94 | 3.18% | $92.89 | $1.86 |
Jun 2024 | 48.4 | 11.6% | $82.28 | $1.7 |
Mar 2024 | 43.37 | 3.91% | $66.36 | $1.53 |
Dec 2023 | 41.74 | -5.76% | $56.76 | $1.36 |
Sep 2023 | 44.29 | -24.96% | $54.48 | $1.23 |
Jun 2023 | 59.02 | 7.78% | $67.28 | $1.14 |
Mar 2023 | 54.76 | 11.85% | $51.47 | $0.94 |
Dec 2022 | 48.96 | -6.3% | $46.02 | $0.94 |
Sep 2022 | 52.25 | 17% | $50.68 | $0.97 |
Jun 2022 | 44.66 | 21.1% | $45.55 | $1.02 |
Mar 2022 | 36.88 | -6.75% | $46.47 | $1.26 |
Dec 2021 | 39.55 | -0.18% | $50.23 | $1.27 |
Sep 2021 | 39.62 | -8.46% | $53.09 | $1.34 |
Jun 2021 | 43.28 | 4.69% | $61.02 | $1.41 |
Currently, LMAT's PE ratio is above its 10-year historical average, but it is lower than the 3 and 5-year averages.
LMAT's PE ratio is less than its peer stocks BSX and TFX, but it is above EW's.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.46 | $42.9B |
LMAT Lemaitre Vascular Inc | 41.76 | $1.85B |
BSX Boston Scientific Corp | 78.17 | $145.36B |
TFX Teleflex Inc | 92.61 | $6.4B |
ANGO Angiodynamics Inc | N/A | $397.37M |
BAX Baxter International Inc | N/A | $16.04B |
LMAT stock has a price to earnings ratio of 44.19 as of Apr 2, 2025.
The average PE ratio for LMAT stock over the past 3 years is 48.58.
The average PE ratio for LMAT stock over the past 5 years is 44.25.
Over the last ten years, the quarterly PE ratio reached a historic high of 59.02 in the Jun 2023 quarter.
LMAT's price to earnings ratio is currently 13% above its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Apr 2, 2025), Lemaitre Vascular's stock price is $86.62. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.96. Therefore, Lemaitre Vascular's price to earnings ratio for today is 44.19. PE RATIO(44.19) = STOCK PRICE($86.62) / TTM EPS($1.96)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.